Today: 21 May 2026
Ondas stock (ONDS) steadies after-hours as resale filing flags new share supply
23 January 2026
2 mins read

Ondas stock (ONDS) steadies after-hours as resale filing flags new share supply

New York, Jan 22, 2026, 19:47 (EST) — After-hours

  • Ondas shares rose roughly 0.5% in after-hours trading, following a choppy session marked by heavy volume
  • The company has filed to register 1.62 million shares for resale related to its acquisition of Sentry CS
  • Investors are also watching an auditor change and a director’s upcoming sale notification as Friday’s session approaches

Ondas Inc shares ticked up 0.5% to $12.62 in after-hours trading Thursday following the filing of a prospectus supplement that registers 1.62 million shares for resale tied to its Sentry CS acquisition. Earlier in the day, the stock fluctuated between $12.36 and $13.33, with volume topping 117 million shares.

Resale registrations are crucial for traders since they convert restricted stock into shares eligible for open market sales. With a name this volatile, it’s not just the block size that counts — it’s whether supply hits the market before demand can absorb it.

Ondas detailed the payment terms for the Sentry deal in its prospectus supplement. The company handed over $117.5 million in cash and issued 4.1 million shares at the closing on Nov. 17. In January, it made two further $2.5 million cash payments, along with issuing more shares, including the batch sold on Thursday. Ondas noted it won’t see any proceeds from these resales, and the sellers face a daily trading limit capped at 10% of average volume.

Ondas is switching auditors alongside its recent filings. The company’s audit committee signed off on dismissing Rosenberg Rich Baker Berman, P.A. after finishing the 2025 audit and submitting the 2025 annual report. BDO USA will take over as auditor for fiscal 2026. Reports from the previous auditor for 2023 and 2024 flagged substantial doubt about Ondas’s ability to continue as a going concern but noted no disputes over accounting or auditing issues.

A separate SEC filing revealed that director Ron Stern submitted a Form 144, signaling a planned sale of up to 100,000 shares valued around $1.42 million. The filing noted approximately 368.5 million shares outstanding and identified Morgan Stanley Smith Barney as the broker.

Oppenheimer’s Timothy Horan boosted his price target for Ondas to $16 from $12, maintaining an Outperform rating, TheFly reported. He highlighted the company’s investor day, noting that management’s long-term guidance seemed conservative given the expansion of its “system of systems” platform. TipRanks

Ondas’ investor day last week set the tone for the recent run-up and subsequent volatility. The company raised its 2026 revenue forecast to $170 million–$180 million and offered preliminary 2025 guidance. That included Q4 revenue of $27 million to $29 million, full-year revenue between $47.6 million and $49.6 million, and a year-end backlog of $65.3 million. Ondas said pro-forma cash topped $1.5 billion and expects to release full results in March.

Ondas bolstered its cash reserves with a $1 billion registered direct offering that wrapped up on Jan. 12. The company sold 19 million shares along with pre-funded warrants covering up to roughly 41.8 million shares, plus warrants to purchase additional stock. It expects net proceeds around $959.2 million, earmarked for corporate development and strategic growth initiatives, including acquisitions.

The company is overhauling its public image. In early January, it announced plans to rename itself Ondas Inc and shifted its headquarters to West Palm Beach, Florida. CEO Eric Brock called the business a “scaled, global defense and security technology platform.” Ondas Inc.

The near-term trade still hinges on supply and follow-through. Resale registrations linked to acquisitions, insider sale alerts, and a hefty warrant overhang can pressure a stock prone to sharp intraday swings. Ambitious targets carry risks too: a misstep in integrating recent buys or a drop in deliveries could swiftly sour sentiment.

Friday’s session will focus on whether the newly registered Sentry-linked shares begin trading and if insider selling picks up pace. Investors are also eyeing the company’s full-year 2025 results, set for March, along with the next payment tranche under the Sentry purchase agreement, which kicks in after the 120-day period following the Nov. 17 closing.

Stock Market Today

  • Australia Shares Set to Rise at Open, New Zealand Markets Dip
    May 20, 2026, 7:49 PM EDT. Australian shares are expected to open higher, signaling investor confidence in the region's market outlook. In contrast, New Zealand equities are projected to decline at the open, reflecting differing economic or market responses. Market data sourced from ICE Data Services with reference information provided by FactSet, supported by multiple financial data providers. The divergence underscores the varied regional market trends in Oceania at the start of the trading session.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900
Previous Story

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week
Next Story

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week

Go toTop